NCT06587360 · Interventional
fertiShare Evaluation
Infertility Assisted Reproductive Technology
Study overall: Recruiting · source record updated 29 July 2025.
3 England locations · 3 explicitly recorded as recruiting.
RESEARCH IN ENGLAND
Explore clinical trials with England locations
Search 2,970 registered studies with identifiable England locations in our dated ClinicalTrials.gov snapshot. Explore the study and local recruitment details before contacting the research team.
208 matching studies · ordered by study identifier.
The area filter uses exact source postcodes. Locations without a matched postcode remain in the England-wide results.
NCT06598163 · Interventional
Five Lives MED to Improve Cognitive Function in Mild Cognitive Impairment
Mild Cognitive Impairment
Study overall: Recruiting · source record updated 29 April 2025.
6 England locations · 3 explicitly recorded as recruiting.
NCT06603844 · Interventional
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Solid Tumor
Study overall: Recruiting · source record updated 3 June 2025.
4 England locations · 0 explicitly recorded as recruiting.
NCT06609226 · Interventional
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Sickle Cell Disease · Thalassemia
Study overall: Recruiting · source record updated 13 August 2026.
8 England locations · 6 explicitly recorded as recruiting.
NCT06610201 · Observational
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Von Willebrand Disease (VWD) · Von Willebrand Disease (VWD), Type 1 · Von Willebrand Disease (VWD), Type 2 · Von Willebrand Disease (VWD), Type 3 · Von Willebrand Disease, Type 2A · Von Willebrand Disease, Type 2M · Von Willebrand Disease, Type 2N
Study overall: Recruiting · source record updated 21 April 2026.
1 England locations · 1 explicitly recorded as recruiting.
NCT06612268 · Interventional
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Sickle Cell Disease
Study overall: Recruiting · source record updated 13 August 2026.
6 England locations · 6 explicitly recorded as recruiting.
NCT06623422 · Interventional
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Carcinoma, Non-Small-Cell Lung
Study overall: Recruiting · source record updated 27 August 2026.
12 England locations · 12 explicitly recorded as recruiting.
NCT06627647 · Interventional
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
Non-squamous Non-small Cell Lung Cancer
Study overall: Recruiting · source record updated 14 August 2026.
8 England locations · 7 explicitly recorded as recruiting.
NCT06659146 · Interventional
Thermotherapy in Addition to SOC Palliative Radiotherapy
Head and Neck Squamous Cell Carcinoma · Cutaneous Squamous Cell Carcinoma · Breast Cancer Recurrent
Study overall: Recruiting · source record updated 22 December 2025.
2 England locations · 2 explicitly recorded as recruiting.
NCT06667076 · Interventional
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Study overall: Recruiting · source record updated 28 August 2026.
6 England locations · 6 explicitly recorded as recruiting.
NCT06687694 · Observational
Immune Mechanisms of Antipsychotic Treatment Response
Psychosis
Study overall: Recruiting · source record updated 25 March 2026.
1 England locations · 1 explicitly recorded as recruiting.
NCT06692738 · Interventional
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Study overall: Recruiting · source record updated 13 August 2026.
8 England locations · 7 explicitly recorded as recruiting.
NCT06697301 · Interventional
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Advanced Melanoma
Study overall: Recruiting · source record updated 8 May 2026.
3 England locations · 3 explicitly recorded as recruiting.
NCT06699849 · Interventional
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Sickle Cell Disease Vaso-occlusive Crisis
Study overall: Recruiting · source record updated 14 August 2026.
1 England locations · 1 explicitly recorded as recruiting.
NCT06712355 · Interventional
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Study overall: Recruiting · source record updated 1 September 2026.
16 England locations · 16 explicitly recorded as recruiting.
NCT06722235 · Interventional
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Immune Thrombocytopenic Purpura (ITP)
Study overall: Recruiting · source record updated 7 August 2026.
9 England locations · 9 explicitly recorded as recruiting.
NCT06731881 · Interventional
Assessing the Efficacy of Photodynamic Therapy for Preventing Surgical Site Infections
Surgery · Nasal Disease · Light; Therapy, Complications
Study overall: Recruiting · source record updated 11 June 2026.
1 England locations · 1 explicitly recorded as recruiting.
NCT06743126 · Interventional
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
Melanoma, Cutaneous Malignant
Study overall: Recruiting · source record updated 18 August 2026.
6 England locations · 5 explicitly recorded as recruiting.
NCT06748001 · Interventional
Avapritinib Rollover Study
Mastocytosis, Systemic
Study overall: Recruiting · source record updated 9 February 2026.
1 England locations · 1 explicitly recorded as recruiting.
NCT06754852 · Interventional
A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Von Willebrand Disease (VWD) · Von Willebrand Disease (VWD), Type 1 · Von Willebrand Disease (VWD), Type 2 · Von Willebrand Disease (VWD), Type 3
Study overall: Recruiting · source record updated 30 June 2026.
8 England locations · 2 explicitly recorded as recruiting.
More ways to explore research
This is a selected international registry feed, not every study taking place in England. NIHR also lists participation opportunities, including studies that may not appear in this selection.
Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).
Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.
How we selected and connected these records
Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.